Div Health DHC Price Action Q3 2024 Profit Surprises CHNR China NatRes publishes quarterly earnings update with full financial metrics and management outlook to be released next week Gilead Sciences GILD Valuation Implications of Expanded Kymera Therapeutics Collaboration and Kymeras FDA Fast Track Designation